V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013328 | 270008883 | 0.98 | 50.9 | Not known (9) | 2013-12-26 | 2014-01-28 | Rituximab (INTRAVENOUS Maintenance) | 02 | N | 270014610 | RITUXIMAB |
| 270013329 | 270008885 | 1.82 | 32.6 | Curative (C) | 2016-03-04 | 2016-03-04 | Rituximab | N | N | 270014610 | RITUXIMAB |
| 270013330 | 270018271 | null | 79.8 | Disease modification (D) | null | 2014-08-08 | Rituximab | N | N | 270014619 | RITUXIMAB |
| 270013331 | 270014181 | 1.76 | 83 | Palliative (P) | 2016-01-09 | 2016-01-13 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 270014620 | CETUXIMAB + IRINOTECAN + MDG |
| 270013332 | 270008887 | 1.85 | 90 | Curative (C) | 2015-01-09 | 2015-01-09 | OEPA | N | N | 270014622 | OEPA |
| 270013333 | 270008889 | 1.8 | 83.2 | Curative (C) | 2017-09-06 | 2017-11-12 | CISPLATIN + RT | N | N | 270014623 | CISPLATIN + RT |
| 270013334 | 270008890 | null | 54.05 | Curative (C) | 2014-02-23 | 2014-03-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 270014624 | CETUXIMAB + IRINOTECAN + MDG |
| 270013335 | 270008890 | 0 | 58.9 | Curative (C) | 2015-02-13 | 2015-03-10 | LEAM | 02 | N | 270014624 | LEAM |
| 270013336 | 270008895 | 1.67 | 84.8 | Curative (C) | 2015-11-24 | 2016-10-12 | Cisplatin + Radiotherapy | N | N | 270014625 | CISPLATIN + RT |
| 270013337 | 270008895 | 1.7 | 90.9 | Curative (C) | 2017-09-18 | 2017-09-21 | ESHAP | 02 | Y | 270014625 | ESHAP |
| 270013338 | 270008900 | 1.74 | 101 | Palliative (P) | 2015-11-17 | 2015-11-17 | Cetuximab + FOLFIRI cycle1 | null | null | 270014630 | CETUXIMAB + IRINOTECAN + MDG |
| 270013339 | 270014187 | 1.52 | 102 | Curative (C) | 2015-03-21 | 2015-03-21 | ESHAP | 2 | N | 270014631 | ESHAP |
| 270013340 | 270008901 | 1.65 | null | Disease modification (D) | 2018-02-06 | 2018-02-07 | LEAM | 2 | N | 270014637 | LEAM |
| 270013341 | 270008902 | 1.7 | 106 | Curative (C) | 2016-02-12 | 2016-02-21 | BEAM | N | N | 270014639 | BEAM |
| 270013342 | 270014188 | 1.7 | 64 | Palliative (P) | 2015-04-02 | 2015-04-04 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014639 | CETUXIMAB + IRINOTECAN + MDG |
| 270013343 | 270008905 | 1.79 | 63.5 | Curative (C) | 2017-10-14 | 2017-12-07 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270014642 | CISPLATIN + RT |
| 270013344 | 270008905 | 1.6 | null | Curative (C) | null | 2016-09-14 | OEPA | N | N | 270014642 | OEPA |
| 270013345 | 270008905 | 1.69 | null | Curative (C) | 2015-02-15 | 2015-02-16 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014642 | CETUXIMAB + IRINOTECAN + MDG |
| 270013346 | 270018275 | 1.91 | 0 | Curative (C) | 2018-08-19 | 2018-08-28 | Cetuximab + FOLFIRI cycle 2 onwards | null | null | 270014646 | CETUXIMAB + IRINOTECAN + MDG |
| 270013347 | 270020061 | 1.64 | 92.9 | Curative (C) | 2016-05-18 | 2016-06-04 | Mini BEAM | N | N | 270014649 | BEAM |
| 270013348 | 270020061 | null | 55 | Curative (C) | 2015-06-22 | 2016-02-04 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014649 | CETUXIMAB + IRINOTECAN + MDG |
| 270013349 | 270008907 | 1.67 | null | Palliative (P) | null | 2016-07-15 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | null | 270014653 | CETUXIMAB + IRINOTECAN + MDG |
| 270013350 | 270008909 | null | 57.7 | Curative (C) | 2014-03-22 | 2014-03-29 | Cisplatin + Radiotherapy | N | N | 270014657 | CISPLATIN + RT |
| 270013351 | 270008909 | 1.74 | 81.8 | Curative (C) | 2014-06-01 | 2015-01-24 | ESHAP | N | N | 270014657 | ESHAP |
| 270013352 | 270008910 | 1.71 | 89 | Curative (C) | 2015-06-06 | 2016-01-02 | ESHAP | null | N | 270014659 | ESHAP |
| 270013353 | 270014193 | 1.75 | 88 | Palliative (P) | 2013-08-15 | 2013-08-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270014660 | CETUXIMAB + IRINOTECAN + MDG |
| 270013354 | 270008914 | 1.6 | 78.4 | Curative (C) | 2017-12-03 | 2017-12-03 | ESHAP | N | N | 270014661 | ESHAP |
| 270013355 | 270008916 | 1.88 | null | Curative (C) | 2017-10-17 | 2017-10-31 | ESHAP | N | N | 270014662 | ESHAP |
| 270013356 | 270008919 | 1.7 | 75 | Curative (C) | 2014-07-18 | 2014-07-24 | BEAM | Y | N | 270014664 | BEAM |
| 270013357 | 270008920 | 1.83 | 17 | Curative (C) | 2013-10-06 | 2013-10-24 | OEPA | N | N | 270014666 | OEPA |
| 270013358 | 270008921 | 1.7 | 93.6 | null | 2015-07-09 | 2015-10-22 | LEAM | null | null | 270014666 | LEAM |
| 270013359 | 270008922 | 1.58 | 59 | Curative (C) | 2012-08-08 | 2013-05-27 | ESHAP | 02 | null | 270014677 | ESHAP |
| 270013360 | 270008923 | 1.88 | 62.2 | Disease modification (D) | 2016-01-17 | 2016-01-23 | CISPLATIN + RT | N | N | 270014678 | CISPLATIN + RT |
| 270013361 | 270008923 | 1.83 | 75.3 | Curative (C) | null | 2016-11-15 | Rituximab | N | null | 270014678 | RITUXIMAB |
| 270013362 | 270014199 | 1.69 | 65.7 | Curative (C) | 2013-12-09 | 2013-12-14 | Rituximab | 02 | N | 270014681 | RITUXIMAB |
| 270013363 | 270014199 | 1.78 | 70 | Palliative (P) | 2014-05-31 | 2014-05-31 | HD EuroNet-PHL-C1 OEPA | N | N | 270014681 | OEPA |
| 270013364 | 270008926 | 1.64 | 29.4 | Curative (C) | 2016-03-04 | 2016-03-10 | ESHAP | N | N | 270014684 | ESHAP |
| 270013365 | 270008927 | 1.8 | 64.5 | Palliative (P) | 2019-04-22 | 2019-04-28 | CETUXIMAB + IRINOTECAN + MDG | N | Y | 270014686 | CETUXIMAB + IRINOTECAN + MDG |
| 270013366 | 270008928 | 1.73 | 48.5 | Curative (C) | 2014-12-03 | 2014-12-15 | Rituximab (Maintenance) | 2 | N | 270014690 | RITUXIMAB |
| 270013367 | 270014201 | 0 | 74.3 | Curative (C) | 2012-01-21 | 2014-08-27 | ESHAP | 02 | N | 270014691 | ESHAP |
| 270013368 | 270008929 | 0 | 68.5 | Curative (C) | 2017-10-11 | 2017-11-08 | CISPLATIN + RT | 02 | null | 270014693 | CISPLATIN + RT |
| 270013369 | 270008930 | 1.55 | 68.5 | Curative (C) | 2016-03-23 | 2016-04-19 | HD EuroNet-PHL-C1 OEPA | N | N | 270014699 | OEPA |
| 270013370 | 270014202 | 1.65 | 40.3 | Palliative (P) | 2014-01-21 | 2014-02-04 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270014699 | CETUXIMAB + IRINOTECAN + MDG |
| 270013371 | 270019144 | 1.81 | 62.4 | Curative (C) | 2016-02-27 | 2016-04-09 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 270014704 | CISPLATIN + RT |
| 270013372 | 270019633 | 1.77 | 68.8 | Curative (C) | null | 2014-08-28 | ESHAP | N | N | 270014705 | ESHAP |
| 270013373 | 270008934 | 1.74 | 101 | Curative (C) | 2013-09-12 | 2014-03-21 | ESHAP | N | N | 270014707 | ESHAP |
| 270013374 | 270008937 | 1.63 | null | Curative (C) | 2017-08-08 | 2017-08-09 | OEPA | N | N | 270014708 | OEPA |
| 270013375 | 270008939 | 1.64 | 90 | Palliative (P) | 2016-09-27 | 2017-01-18 | BEAM | 02 | N | 270014715 | BEAM |
| 270013376 | 270014204 | 1.77 | 54 | Disease modification (D) | 2018-01-30 | 2018-02-07 | BEAM | 02 | null | 270014717 | BEAM |
| 270013377 | 270014204 | 1.56 | 117 | Disease modification (D) | 2016-01-03 | 2016-01-15 | Rituximab (Maintenance) | N | N | 270014717 | RITUXIMAB |